Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Supportive Oncology|August 28, 2004
Managing hematologic toxicitiesGerardo Capo, Roger Waltzman
The Journal of Supportive Oncology|February 3, 2007
Communicating about chemotherapy-induced anemiaBrad Davidson, Diane Blum, David Cella, et al.
The Oncologist|September 24, 2005
Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapyRoger Waltzman, Christopher Croot, Glen R Justice, et al.
Haematologica|August 4, 2009
High rates of durable response are achieved with imatinib after treatment with interferon alpha plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trialFrançois Guilhot, Brian Druker, Richard A Larson, et al.
Diseases of the Colon and Rectum|December 11, 2007
Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapyAnn Wexler, Anthony M Berson, Stephen E Goldstone, et al.
The New England Journal of Medicine|March 2, 2012
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosisClaire Harrison, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, et al.
Pageof 1